Affected by the epidemic situation in novel coronavirus at the beginning of this year, the public's concept of health protection has been deepened, and domestic and foreign automobile manufacturers have paid special attention to it, so as to improve the safety protection ability of their own brand cars and bring better driving experience to passengers. At the same time, pharmaceutical companies have also conducted in-depth research on health protection to create healthier and more effective products.
It is reported that Changan Automobile and Sinopharm Group will carry out a new situation of cross-border cooperation on this cooperation, lead the new concept of healthy cars and redefine the new format. Give full play to their respective advantages in their respective fields, take "mutual benefit, mutual promotion and common development" as the basic principle, and finally reach comprehensive strategic cooperation. Prior to this, Changan Automobile has taken the lead in independently developing "PM0. 1 high-efficiency composite antiviral filter". I believe that on this basis, this cooperation will definitely make great progress.
This article comes from car home, the author of the car manufacturer, and does not represent car home's position.